T. Tyurina

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, The Lancet.

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.

Specificity of Growth and Synthesis of Secondary Metabolites in Cultures in vitro Digitalis lanata Ehrh.

A. Nosov, D. Kochkin, T. Tyurina, 2022, Russian Journal of Plant Physiology.

Growth and biosynthetic profiles of callus and suspension cell cultures of two rare foxglove species, Digitalis grandiflora Mill. and D. ciliata Trautv.

A. Nosov, D. Kochkin, T. Tyurina, 2022, Plant Cell, Tissue and Organ Culture (PCTOC).

Specificity of Growth and Synthesis of Secondary Metabolites in Cultures in vitro Digitalis lanata Ehrh.

D. Kochkin, T. Tyurina, B. A. Galishev, 2022, Russian Journal of Plant Physiology.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.

W. E. Sanabria, John A. Hamling, Ju Han Kim, 2019, Lancet.